Literature DB >> 23829446

Reconstructed skin models as emerging tools for drug absorption studies.

Sarah Küchler1, Kay Strüver, Wolfgang Friess.   

Abstract

INTRODUCTION: As humans can come into contact with xenobiotics intentionally or accidentally, knowledge about the skin absorption of these substances is crucial and requires reliable models and test procedures. Animal experiments should be avoided whenever possible, instead of making the use of in vitro systems. Furthermore, due to limited availability of normal and especially diseased human skin, alternative test systems such as reconstructed skin models are urgently required. AREAS COVERED: This article discusses the advantages and limitations of excised human skin, animal skin and reconstructed skin models for absorption testing in vitro. Furthermore, the authors also describe the standard procedure for skin absorption testing and give an excursion to the applicability of artificial membranes. Finally, the article highlights the progress in the development of reconstructed disease models and provides an extensive overview about past and ongoing research in this field. EXPERT OPINION: The development and validation of in vitro systems for skin absorption testing is inevitable. More research efforts are required for the development of reconstructed disease models. Reconstructed skin models need to be improved, especially in terms of complexity to mimic the in vivo situation better. It should not, however, be the main goal to imitate the in vivo situation exactly, but to establish reliable systems that ensure predictive and reliable data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23829446     DOI: 10.1517/17425255.2013.816284

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  8 in total

1.  Microneedle-assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel.

Authors:  Atul Nayak; Diganta B Das; Goran T Vladisavljević
Journal:  Pharm Res       Date:  2013-11-08       Impact factor: 4.200

2.  Current advances in skin-on-a-chip models for drug testing.

Authors:  Qiang Zhang; Linda Sito; Mao Mao; Jiankang He; Yu Shrike Zhang; Xin Zhao
Journal:  Microphysiol Syst       Date:  2018-08-30

3.  Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety.

Authors:  Fátima Pinto; Luis P Fonseca; Dragana P C de Barros
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Small, Cationic Antifungal Proteins from Filamentous Fungi Inhibit Candida albicans Growth in 3D Skin Infection Models.

Authors:  Jeanett Holzknecht; Sandrine Dubrac; Sarah Hedtrich; László Galgóczy; Florentine Marx
Journal:  Microbiol Spectr       Date:  2022-05-02

Review 5.  Skin models for the testing of transdermal drugs.

Authors:  Eman Abd; Shereen A Yousef; Michael N Pastore; Krishna Telaprolu; Yousuf H Mohammed; Sarika Namjoshi; Jeffrey E Grice; Michael S Roberts
Journal:  Clin Pharmacol       Date:  2016-10-19

6.  TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents.

Authors:  Leonie Wallmeyer; Kristina Dietert; Michaela Sochorová; Achim D Gruber; Burkhard Kleuser; Kateřina Vávrová; Sarah Hedtrich
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

Review 7.  Microfluidic-Based Multi-Organ Platforms for Drug Discovery.

Authors:  Ahmad Rezaei Kolahchi; Nima Khadem Mohtaram; Hassan Pezeshgi Modarres; Mohammad Hossein Mohammadi; Armin Geraili; Parya Jafari; Mohsen Akbari; Amir Sanati-Nezhad
Journal:  Micromachines (Basel)       Date:  2016-09-08       Impact factor: 2.891

8.  3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells.

Authors:  Anastasia Petrova; Anna Celli; Laureen Jacquet; Dimitra Dafou; Debra Crumrine; Melanie Hupe; Matthew Arno; Carl Hobbs; Aleksandra Cvoro; Panagiotis Karagiannis; Liani Devito; Richard Sun; Lillian C Adame; Robert Vaughan; John A McGrath; Theodora M Mauro; Dusko Ilic
Journal:  Stem Cell Reports       Date:  2014-04-24       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.